Treatment of Severe Hypertension with Methyldopa
- 19 January 1963
- Vol. 1 (5324) , 151-155
- https://doi.org/10.1136/bmj.1.5324.151
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Another Hypotensive Agent--MethyldopaBMJ, 1962
- METHYLDOPA IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- Agranulocytosis caused by methyl dopa (Aldomet).1961
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- Serotonin Synthesis in Carcinoid PatientsNew England Journal of Medicine, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Hypertension--Treated and UntreatedBMJ, 1959
- [Inhibition of serotonin formation by alpha-methyl-DOPA].1958
- Inhibition of dihydroxyphenylalanine decarboxylase by derivatives of phenylalanineArchives of Biochemistry and Biophysics, 1954